Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Líder de la industria
Los ingresos de la empresa lideran el sector. Sus ingresos anuales más recientes ascienden a 44.56B USD.
Alto dividendo
La empresa es una gran pagadora de dividendos. Su ratio de pago de dividendos más reciente es del 9.41%.
Dividendo estable
La empresa ha pagado dividendos de forma regular durante los últimos 5 años. Su ratio de pago de dividendos más reciente es del 9.41%.
Infravalorada
El PE más reciente de la empresa es 25.45, en un rango percentil bajo de 3 años.
Venta institucional
Las tenencias institucionales más recientes son 353.25M acciones, lo que supone una reducción del 0.73% con respecto al trimestre anterior.
En posesión de EDGEPOINT CANADIAN PORTFOLIO
El inversor estrella EDGEPOINT CANADIAN PORTFOLIO posee 2.07M acciones de este valor.